India Begs Novartis To Drop Patent Challenge

Law360, New York (April 10, 2007, 12:00 AM EDT) -- India’s health minister is calling for Novartis AG to back down from its controversial legal battle to patent Gleevec in the country, reportedly arguing that the Swiss drug maker’s challenge to a key section of India’s patent laws could block global access to affordable drugs.

Union Health Minister Anbumani Ramadoss urged Novartis to withdraw its patent challenge, stating that he is “very concerned” that the outcome of the lawsuit could affect the global supply of cheap AIDS drugs, Reuters reported Tuesday.

Ramadoss added that if Novartis...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.